[1] | Zhou DW, Zhang YY, Wu HT, Barry E, Yin Y, Lawrence E, Dawson D, Willis JE, Markowitz SD, Camargo FD, Avruch J. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA, 2011, 108(49): E1312-E1320. | [2] | Zhou Q, Li L, Zhao B, Guan KL. The hippo pathway in heart development, regeneration, and diseases. Circ Res, 2015, 116(8): 1431-1447. | [3] | Zhou DW, Medoff BD, Chen LF, Li LQ, Zhang XF, Praskova M, Liu M, Landry A, Blumberg RS, Boussiotis VA, Xavier R, Avruch J. The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of na?ve T cells. Proc Natl Acad Sci USA, 2008, 105(51): 20321-20326. | [4] | Geng J, Sun XF, Wang P, Zhang SH, Wang XZ, Wu HT, Hong LX, Xie CC, Li X, Zhao H, Liu QX, Jiang MT, Chen QH, Zhang JJ, Li Y, Song SY, Wang HR, Zhou RB, Johnson RL, Chien KY, Lin SC, Han JH, Avruch J, Chen LF, Zhou DW. Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity. Nat Immunol, 2015, 16(11): 1142-1152. | [5] | Yu FX, Guan KL. The Hippo pathway: regulators and regulations. Genes Dev, 2013, 27(4): 355-371. | [6] | Huang JB, Wu SA, Barrera J, Matthews K, Pan DJ. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell, 2005, 122(3): 421-434. | [7] | Wu SA, Huang JB, Dong JC, Pan DJ. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell, 2003, 114(4): 445-456. | [8] | Chan EHY, Nousiainen M, Chalamalasetty RB, Sch?fer A, Nigg EA, Silljé HHW. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene, 2005, 24(12): 2076-2086. | [9] | Yin F, Yu JZ, Zheng YG, Chen Q, Zhang NL, Pan DJ. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell, 2013, 154(6): 1342-1355. | [10] | Hamaratoglu F, Willecke M, Kango-Singh M, Nolo R, Hyun E, Tao C, Jafar-Nejad H, Halder G. The tumour- suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol, 2006, 8(1): 27-36. | [11] | Bennett FC, Harvey KF. Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway. Curr Biol, 2006, 16(21): 2101-2110. | [12] | Greenbaum LE. The ductal plate: a source of progenitors and hepatocytes in the adult liver. Gastroenterology, 2011, 141(4): 1152-1155. | [13] | Zhang NL, Bai HB, David KK, Dong JX, Zheng YG, Cai J, Giovannini M, Liu PT, Anders RA, Pan DJ. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell, 2010, 19(1): 27-38. | [14] | Fitamant J, Kottakis F, Benhamouche S, Tian HS, Chuvin N, Parachoniak CA, Nagle JM, Perera RM, Lapouge M, Deshpande V, Zhu AX, Lai A, Min B, Hoshida Y, Avruch J, Sia D, Campreciós G, McClatchey AI, Llovet JM, Morrissey D, Raj L, Bardeesy N. YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression. Cell Rep, 2015, 10(10): 1692-1707. | [15] | Alder O, Cullum R, Lee S, Kan AC, Wei W, Yi YY, Garside VC, Bilenky M, Griffith M, Morrissy AS, Robertson GA, Thiessen N, Zhao YJ, Chen Q, Pan DJ, Jones SJM, Marra MA, Hoodless PA. Hippo signaling influences HNF4A and FOXA2 enhancer switching during hepatocyte differentiation. Cell Rep, 2014, 9(1): 261-271. | [16] | Yimlamai D, Christodoulou C, Galli GG, Yanger K, Pepe-Mooney B, Gurung B, Shrestha K, Cahan P, Stanger BZ, Camargo FD. Hippo pathway activity influences liver cell fate. Cell, 2014, 157(6): 1324-1338. | [17] | Hofmann JJ, Zovein AC, Koh H, Radtke F, Weinmaster G, Iruela-Arispe ML. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome. Development, 2010, 137(23): 4061-4072. | [18] | Lee DH, Park JO, Kim TS, Kim SK, Kim TH, Kim MC, Park GS, Kim JH, Kuninaka S, Olson EN, Saya H, Kim SY, Lee H, Lim DS. LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development. Nat Commun, 2016, 7: 11961. | [19] | Bai HB, Zhang NL, Xu Y, Chen Q, Khan M, Potter JJ, Nayar SK, Cornish T, Alpini G, Bronk S, Pan DJ, Anders RA. Yes-associated protein regulates the hepatic response after bile duct ligation. Hepatology, 2012, 56(3): 1097-1107. | [20] | Wu HT, Xiao YB, Zhang SH, Ji SY, Wei LY, Fan FQ, Geng J, Tian J, Sun XF, Qin FN, Jin CN, Lin JJ, Yin ZY, Zhang T, Luo LZ, Li Y, Song SY, Lin SC, Deng XM, Camargo F, Avruch J, Chen LF, Zhou DW. The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense. Cell Rep, 2013, 3(5): 1663-1677. | [21] | Zhou DW, Conrad C, Xia F, Park JS, Payer B, Yin Y, Lauwers GY, Thasler W, Lee JT, Avruch J, Bardeesy N. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell, 2009, 16(5): 425-438. | [22] | Dong JX, Feldmann G, Huang JB, Wu SA, Zhang NL, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan DJ. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell, 2007, 130(6): 1120-1133. | [23] | Harada N, Oshima H, Katoh M, Tamai Y, Oshima M, Taketo MM. Hepatocarcinogenesis in mice with β-catenin and Ha-ras gene mutations. Cancer Res, 2004, 64(1): 48-54. | [24] | Benhamouche S, Curto M, Saotome I, Gladden AB, Liu CH, Giovannini M, McClatchey AI. Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes Dev, 2010, 24(16): 1718-1730. | [25] | Song H, Mak KK, Topol L, Yun KS, Hu JX, Garrett L, Chen YB, Park O, Chang J, Simpson RM, Wang CY, Gao B, Jiang J, Yang YZ. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA, 2010, 107(4): 1431-1436. | [26] | Lu L, Li Y, Kim SM, Bossuyt W, Liu P, Qiu Q, Wang YD, Halder G, Finegold MJ, Lee JS, Johnson RL. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA, 2010, 107(4): 1437-1442. | [27] | Lee KP, Lee JH, Kim TS, Kim TH, Park HD, Byun JS, Kim MC, Jeong WI, Calvisi DF, Kim JM, Lim DS. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA, 2010, 107(18): 8248-8253. | [28] | Yi J, Lu L, Yanger K, Wang WQ, Sohn BH, Stanger BZ, Zhang M, Martin JF, Ajani JA, Chen JJ, Lee JS, Song SM, Johnson RL. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ. Hepatology, 2016, 64(5): 1757-1772. | [29] | Nishio M, Sugimachi K, Goto H, Wang J, Morikawa T, Miyachi Y, Takano Y, Hikasa H, Itoh T, Suzuki SO, Kurihara H, Aishima S, Leask A, Sasaki T, Nakano T, Nishina H, Nishikawa Y, Sekido Y, Nakao K, Shin-Ya K, Mimori K, Suzuki A. Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b- deficient mice. Proc Natl Acad Sci USA, 2016, 113(1): E71-E80. | [30] | Camargo FD, Gokhale S, Johnnidis JB, Fu DD, Bell GW, Jaenisch R, Brummelkamp TR. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol, 2007, 17(23): 2054-2060. | [31] | Lemaigre FP. Development of the biliary tract. Mech Dev, 2003, 120(1): 81-87. | [32] | Geisler F, Nagl F, Mazur PK, Lee M, Zimber-Strobl U, Strobl LJ, Radtke F, Schmid RM, Siveke JT. Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice. Hepatology, 2008, 48(2): 607-616. | [33] | Moroishi T, Park HW, Qin BD, Chen Q, Meng ZP, Plouffe SW, Taniguchi K, Yu FX, Karin M, Pan DJ, Guan KL. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Genes Dev, 2015, 29(12): 1271-1284. | [34] | Jungermann K, Katz N. Functional specialization of different hepatocyte populations. Physiol Rev, 1989, 69(3): 708-764. | [35] | Oh S, Lee D, Kim T, Kim TS, Oh HJ, Hwang CY, Kong YY, Kwon KS, Lim DS. Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. Mol Cell Biol, 2009, 29(23): 6309-6320. | [36] | McClatchey AI, Saotome I, Mercer K, Crowley D, Gusella JF, Bronson RT, Jacks T. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev, 1998, 12(8): 1121-1133. | [37] | Chen Q, Zhang NL, Xie R, Wang W, Cai J, Choi KS, David KK, Huang B, Yabuta N, Nojima H, Anders RA, Pan DJ. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP. Genes Dev, 2015, 29(12): 1285-1297. | [38] | Nishio M, Hamada K, Kawahara K, Sasaki M, Noguchi F, Chiba S, Mizuno K, Suzuki SO, Dong YY, Tokuda M, Morikawa T, Hikasa H, Eggenschwiler J, Yabuta N, Nojima H, Nakagawa K, Hata Y, Nishina H, Mimori K, Mori M, Sasaki T, Mak TW, Nakano T, Itami S, Suzuki A. Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice. J Clin Invest, 2012, 122(12): 4505-4518. | [39] | Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer, 2006, 6(9): 674-687. | [40] | Jie L, Fan W, Wei QD, Ying QZ, Ling X, Miao S, Ping C, Chuan YG. The hippo-yes association protein pathway in liver cancer. Gastroenterol Res Pract, 2013, ( 2013-8-6), 2013, 2013(3): 187070. | [41] | Zender L, Spector MS, Xue W, Flemming P, Cordon- Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, Mu D, Lucito R, Powers S, Lowe SW. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell, 2006, 125(7): 1253-1267. | [42] | Xu MZ, Yao TJ, Lee NPY, Ng IOL, Chan YT, Zender L, Lowe SW, Poon RTP, Luk JM. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer, 2009, 115(19): 4576-4585. | [43] | Tu KS, Yang W, Li C, Zheng X, Lu ZT, Guo C, Yao YM, Liu QG. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Mol Cancer, 2014, 13: 110. | [44] | Mao B, Hu F, Cheng J, Wang P, Xu M, Yuan F, Meng S, Wang Y, Yuan Z, Bi W. SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma. Oncogene, 2014, 33(11): 1468-1474. | [45] | Anakk S, Bhosale M, Schmidt VA, Johnson RL, Finegold MJ, Moore DD. Bile acids activate YAP to promote liver carcinogenesis. Cell Rep, 2013, 5(4): 1060-1069. | [46] | Zhao B, Wei XM, Li WQ, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu JD, Li L, Zheng P, Ye KQ, Chinnaiyan A, Halder G, Lai ZC, Guan KL. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev, 2007, 21(21): 2747-2761. | [47] | Overholtzer M, Zhang JM, Smolen GA, Muir B, Li WM, Sgroi DC, Deng CX, Brugge JS, Haber DA. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA, 2006, 103(33): 12405-12410. | [48] | Kim GJ, Kim H, Park YN. Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma. PLoS One, 2013, 8(9): e75449. | [49] | Leung CON, Mak WN, Kai AKL, Chan KS, Lee TKW, Ng IOL, Lo RCL. Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/ β-catenin signaling. Oncotarget, 2016, 7(20): 29371-29386. | [50] | Wang XB, Zheng Z, Caviglia JM, Corey KE, Herfel T, Cai BS, Masia R, Chung RT, Lefkowitch JH, Schwabe RF, Tabas I. Hepatocyte TAZ/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis. Cell Metab, 2016, 24(6): 848-862. | [51] | Zhang DY, Friedman SL. Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology, 2012, 56(2): 769-775. | [52] | Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, Liu JO, Pan DJ. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev, 2012, 26(12): 1300-1305. | [53] | Liu AM, Xu MZ, Chen JF, Poon RT, Luk JM. Targeting YAP and Hippo signaling pathway in liver cancer. Expert Opin Ther Targets, 2010, 14(8): 855-868. | [54] | Perra A, Kowalik MA, Ghiso E, Ledda-Columbano GM, Di Tommaso L, Angioni MM, Raschioni C, Testore E, Roncalli M, Giordano S, Columbano A. YAP activation is an early event and a potential therapeutic target in liver cancer development. J Hepatol, 2014, 61(5): 1088-1096. | [55] | Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology, 2006, 43(S1): S45-S53. | [56] | Michalopoulos GK. Liver regeneration after partial hepatectomy. Am J Pathol, 2010, 176(1): 2-13. | [57] | Udan RS, Kango-Singh M, Nolo R, Tao CY, Halder G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol, 2003, 5(10): 914-920. | [58] | Harvey KF, Pfleger CM, Hariharan IK. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell, 2003, 114(4): 457-467. | [59] | Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol, 2011, 13(8): 877-883. | [60] | Xin M, Kim Y, Sutherland LB, Murakami M, Qi XX, McAnally J, Porrello ER, Mahmoud AI, Tan W, Shelton JM, Richardson JA, Sadek HA, Bassel-Duby R, Olson EN. Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci USA, 2013, 110(34): 13839-13844. | [61] | Karpowicz P, Perez J, Perrimon N. The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration. Development, 2010, 137(24): 4135-4145. | [62] | Grijalva JL, Huizenga M, Mueller K, Rodriguez S, Brazzo J, Camargo F, Sadri-Vakili G, Vakili K. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol, 2014, 307(2): G196-G204. | [63] | Fan FQ, He ZX, Kong LL, Chen QH, Yuan Q, Zhang SH, Ye JJ, Liu H, Sun XF, Geng J, Yuan LZ, Hong LX, Xiao C, Zhang WJ, Sun XH, Li YZ, Wang P, Huang LH, Wu XR, Ji ZL, Wu Q, Xia NS, Gray NS, Chen LF, Yun CH, Deng XM, Zhou DW. Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. Sci Transl Med, 2016, 8(352): 352ra108. | [64] | Loforese G, Malinka T, Keogh A, Baier F, Simillion C, Montani M, Halazonetis TD, Candinas D, Stroka D. Impaired liver regeneration in aged mice can be rescued by silencing Hippo core kinases MST1 and MST2. EMBO Mol Med, 2017, 9(1): 46-60. | [65] | Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, Kuhara T, Hosokawa S, Elbahrawy A, Soeda T, Koizumi M, Masui T, Kawaguchi M, Takaori K, Doi R, Nishi E, Kakinoki R, Deng JM, Behringer RR, Nakamura T, Uemoto S. Continuous cell supply from a Sox9- expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet, 2011, 43(1): 34-41. | [66] | Zhao B, Ye X, Yu JD, Li L, Li WQ, Li SM, Yu JJ, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev, 2008, 22(14): 1962-1971. | [67] | Bai HB, Gayyed MF, Lam-Himlin DM, Klein AP, Nayar SK, Xu Y, Khan M, Argani P, Pan DJ, Anders RA. Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies. Hum Pathol, 2012, 43(9): 1376-1385. |
|